TradingView
MarketsRadar
8 gen 2021 22:45
Long BIIB
NASDAQ:BIIB
1D
Biogen Inc.
NASDAQ
Descrizione
⋅
8 gen 2021 22:45
BIIB Daily Chart , Not a High Quality Trade!
Trade chiuso: obiettivo raggiunto
⋅
15 gen 2021 21:26
Boooom
Trend Analysis
Commenti
Soartrader1
⋅
9 gen 2021 05:28
It will be a high quality trade if BIIB reruns their clinical trial on Aducanumab @10mg/kg, factors out the APO-E carriers and can show statistical improvement in cognition without adverse side effects. Will know by March if they hold an ace
Altro